tiprankstipranks
Trending News
More News >
Cannomed Medical Cannabis Industries Ltd. (IL:GEFR)
:GEFR
Israel Market

Cannomed (GEFR) Income Statement

Compare
0 Followers

Cannomed Income Statement

Last quarter (Q3 2025), Cannomed's total revenue was 20.00K, a decrease of -42.86% from the same quarter last year. In Q3, Cannomed's net income was -1.46M. See Cannomed’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
131.00K 142.00K 60.00K 658.00K 17.92M
Gross Profit
131.00K 142.00K -5.93M -10.22M 4.83M
Operating Expenses
6.33M 6.92M 4.32M 5.45M 9.92M
Depreciation and Amortization
339.00K 518.00K 2.14M 1.96M 605.00K
EBITDA
-5.58M -6.11M -16.48M -18.18M -5.29M
Operating Income
-6.20M -6.78M -18.88M -20.16M -9.60M
Other Income/Expenses
717.00K 111.00K -146.00K -894.00K -1.41M
Pretax Income
-6.20M -6.67M -19.02M -21.05M -11.15M
Net Income
-5.07M -6.91M -20.08M -13.43M -8.81M
Per Share Metrics
Basic EPS
-0.02 -0.03 -0.20 -0.15 -0.10
Diluted EPS
-0.02 -0.03 -0.20 -0.15 -0.10
Weighted Average Shares Outstanding
256.25M 251.19M 99.39M 88.04M 86.25M
Weighted Average Shares Outstanding (Diluted)
256.25M 215.64M 99.39M 88.04M 86.25M
Currency in ILS

Cannomed Earnings and Revenue History